Baudax Bio BXRX Stock
Baudax Bio Price Chart
Baudax Bio BXRX Financial and Trading Overview
| Baudax Bio stock price | 0.19 USD |
| Previous Close | 0.58 USD |
| Open | 0.55 USD |
| Bid | 0 USD x 2900 |
| Ask | 0 USD x 800 |
| Day's Range | 0.55 - 0.57 USD |
| 52 Week Range | 0.5 - 37.72 USD |
| Volume | 81.23K USD |
| Avg. Volume | 1.09M USD |
| Market Cap | 3.4M USD |
| Beta (5Y Monthly) | 1.551809 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24 USD |
BXRX Valuation Measures
| Enterprise Value | 7.69M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.5090909 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6759787 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.063 |
| Enterprise Value/EBITDA | -0.236 |
Trading Information
Baudax Bio Stock Price History
| Beta (5Y Monthly) | 1.551809 |
| 52-Week Change | -98.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 37.72 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 1 USD |
| 200-Day Moving Average | 4.31 USD |
BXRX Share Statistics
| Avg. Volume (3 month) | 1.09M USD |
| Avg. Daily Volume (10-Days) | 326.88K USD |
| Shares Outstanding | 6.06M |
| Float | 6.06M |
| Short Ratio | 0.22 |
| % Held by Insiders | 0.061% |
| % Held by Institutions | 46.00% |
| Shares Short | 59.75K |
| Short % of Float | 0.99% |
| Short % of Shares Outstanding | 0.99% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2584.94% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.38% |
| Return on Equity (ttm) | -4772.59% |
Income Statement
| Revenue (ttm) | 1.27M USD |
| Revenue Per Share (ttm) | 1.43 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -5740000 USD |
| EBITDA | -32649000 USD |
| Net Income Avi to Common (ttm) | -57987000 USD |
| Diluted EPS (ttm) | -102.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.8M USD |
| Total Cash Per Share (mrq) | 0.63 USD |
| Total Debt (mrq) | 8.01M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.332 |
| Book Value Per Share (mrq) | -2.828 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25959000 USD |
| Levered Free Cash Flow (ttm) | -21458250 USD |
Profile of Baudax Bio
| Country | United States |
| State | PA |
| City | Malvern |
| Address | 490 Lapp Road |
| ZIP | 19355 |
| Phone | 484 395 2440 |
| Website | https://www.baudaxbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.
Q&A For Baudax Bio Stock
What is a current BXRX stock price?
Baudax Bio BXRX stock price today per share is 0.19 USD.
How to purchase Baudax Bio stock?
You can buy BXRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Baudax Bio?
The stock symbol or ticker of Baudax Bio is BXRX.
Which industry does the Baudax Bio company belong to?
The Baudax Bio industry is Biotechnology.
How many shares does Baudax Bio have in circulation?
The max supply of Baudax Bio shares is 0.
What is Baudax Bio Price to Earnings Ratio (PE Ratio)?
Baudax Bio PE Ratio is now.
What was Baudax Bio earnings per share over the trailing 12 months (TTM)?
Baudax Bio EPS is 0 USD over the trailing 12 months.
Which sector does the Baudax Bio company belong to?
The Baudax Bio sector is Healthcare.
Baudax Bio BXRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Capital Market Composite RCMP | 102.11 USD — |
-0.04
|
— — | 100.72 USD — | 103.65 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}